Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Huge Collagen II Biotechnology is a specialized biotechnology firm based in China that focuses on the research, development, and production of undenatured type II collagen. The company employs advanced low-temperature extraction techniques to maintain the biological activity and triple-helix structure of collagen derived from chicken sternal cartilage. Its products are primarily utilized in nutraceutical formulations aimed at treating joint-related conditions such as osteoarthritis and rheumatoid arthritis through the mechanism of oral tolerance. As a major manufacturer, the company provides high-quality raw materials and finished supplements to international markets, adhering to strict quality control and manufacturing standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Huge Collagen II Biotechnology.